Functional complementation of nucleocapsid and late domain PTAP mutants of human immunodeficiency virus type 1 during replication

Virology

Volumn 375, Issue 2, 2008, Pages 539-549

  Nikolaitchik, Olga A ^a   Gorelick, Robert J ^b   Leavitt, Maria G ^a   Pathak, Vinay K ^a   Hu, Wei Shau ^a  

^a HIV Drug Resistance Program   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

Complementation; HIV; Nucleocapsid; PTAP late domain; Replication

Indexed keywords

GAG PROTEIN; NUCLEOCAPSID PROTEIN; VIRUS DNA; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DNA INTEGRATION; DNA STRAND; DNA SYNTHESIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION; VIRUS MUTATION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION;

CELL LINE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV-1; HUMANS; NUCLEOCAPSID; PROTEIN STRUCTURE, TERTIARY; RNA, VIRAL; VIRUS ASSEMBLY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 43249116792     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.02.026     Document Type: Article

References (84)

1. Bennett R.P., and Wills J.W. Conditions for copackaging Rous sarcoma virus and murine leukemia virus Gag proteins during retroviral budding. J. Virol. 73 3 (1999) 2045-2051
2. Bennett R.P., Rhee S., Craven R.C., Hunter E., and Wills J.W. Amino acids encoded downstream of gag are not required by Rous sarcoma virus protease during gag-mediated assembly. J. Virol. 65 1 (1991) 272-280
3. Bennett R.P., Nelle T.D., and Wills J.W. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins. J. Virol. 67 11 (1993) 6487-6498
4. Berg J.M. Potential metal-binding domains in nucleic acid binding proteins. Science 232 4749 (1986) 485-487
5. Berkowitz R.D., Ohagen A., Hoglund S., and Goff S.P. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo. J. Virol. 69 10 (1995) 6445-6456
6. Berkowitz R., Fisher J., and Goff S.P. RNA packaging. Curr. Top. Microbiol. Immunol. 214 (1996) 177-218
7. Bowles N.E., Damay P., and Spahr P.F. Effect of rearrangements and duplications of the Cys-His motifs of Rous sarcoma virus nucleocapsid protein. J. Virol. 67 2 (1993) 623-631
8. Bowzard J.B., Bennett R.P., Krishna N.K., Ernst S.M., Rein A., and Wills J.W. Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue. J. Virol. 72 11 (1998) 9034-9044
9. Boyko V., Leavitt M., Gorelick R., Fu W., Nikolaitchik O., Pathak V.K., Nagashima K., and Hu W.S. Coassembly and complementation of Gag proteins from HIV-1 and HIV-2, two distinct human pathogens. Mol. Cell. 23 2 (2006) 281-287
10. Brule F., Marquet R., Rong L., Wainberg M.A., Roques B.P., Le Grice S.F., Ehresmann B., and Ehresmann C. Structural and functional properties of the HIV-1 RNA-tRNA(Lys)3 primer complex annealed by the nucleocapsid protein: comparison with the heat-annealed complex. Rna 8 1 (2002) 8-15
11. Bryant M., and Ratner L. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. U. S. A. 87 2 (1990) 523-527
12. Buckman J.S., Bosche W.J., and Gorelick R.J. Human immunodeficiency virus type 1 nucleocapsid Zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA. J. Virol. 77 2 (2003) 1469-1480
13. Butler S.L., Hansen M.S., and Bushman F.D. A quantitative assay for HIV DNA integration in vivo. Nat. Med. 7 5 (2001) 631-634
14. Campbell S., and Vogt V.M. In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in he formation of spherical particles. J. Virol. 71 6 (1997) 4425-4435
15. Campbell S., and Rein A. In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J. Virol. 73 3 (1999) 2270-2279
16. Carteau S., Gorelick R.J., and Bushman F.D. Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: stimulation by the viral nucleocapsid protein. J. Virol. 73 8 (1999) 6670-6679
17. Cen S., Khorchid A., Gabor J., Rong L., Wainberg M.A., and Kleiman L. Roles of Pr55(gag) and NCp7 in tRNA(3) (Lys) genomic placement and the initiation step of reverse transcription in human immunodeficiency virus type 1. J. Virol. 74 22 (2000) 10796-10800
18. Certo J.L., Kabdulov T.O., Paulson M.L., Anderson J.A., and Hu W.S. The nucleocapsid domain is responsible for the ability of spleen necrosis virus (SNV) Gag polyprotein to package both SNV and murine leukemia virus RNA. J. Virol. 73 11 (1999) 9170-9177
19. Chen C., Vincent O., Jin J., Weisz O.A., and Montelaro R.C. Functions of early (AP-2) and late (AIP1/ALIX) endocytic proteins in equine infectious anemia virus budding. J. Biol. Chem. 280 49 (2005) 40474-40480
20. Cline A.N., Bess J.W., Piatak Jr. M., and Lifson J.D. Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J. Med. Primatol. 34 5-6 (2005) 303-312
21. Craven R.C., Leure-duPree A.E., Weldon Jr. R.A., and Wills J.W. Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. J. Virol. 69 7 (1995) 4213-4227
22. Demirov D.G., Ono A., Orenstein J.M., and Freed E.O. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl. Acad. Sci. U. S. A. 99 2 (2002) 955-960
23. Demirov D.G., Orenstein J.M., and Freed E.O. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner. J. Virol. 76 1 (2002) 105-117
24. Derdowski A., Ding L., and Spearman P. A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interactions. J. Virol. 78 3 (2004) 1230-1242
25. Dettenhofer M., and Yu X.F. Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins. J. Virol. 73 6 (1999) 4696-4704
26. Dong X., Li H., Derdowski A., Ding L., Burnett A., Chen X., Peters T.R., Dermody T.S., Woodruff E., Wang J.J., and Spearman P. AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell 120 5 (2005) 663-674
27. DuBridge R.B., Tang P., Hsia H.C., Leong P.M., Miller J.H., and Calos M.P. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7 1 (1987) 379-387
28. Fisher R.D., Chung H.Y., Zhai Q., Robinson H., Sundquist W.I., and Hill C.P. Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell 128 5 (2007) 841-852
29. Freed E.O. HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 251 1 (1998) 1-15
30. Freed E.O., and Martin M.A. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70 1 (1996) 341-351
31. Freed E.O., and Martin M.A. "Retroviridae: the retroviruses and their replication.". In: David P.M.H., and Knipes M. (Eds). Fields Virology. fifth ed. II (2007), Lippincott William and Wilkins, Piladelphia, PA, USA II
32. Fu W., Dang Q., Nagashima K., Freed E.O., Pathak V.K., and Hu W.S. Effects of Gag mutation and processing on retroviral dimeric RNA maturation. J. Virol. 80 3 (2006) 1242-1249
33. Garrus J.E., von Schwedler U.K., Pornillos O.W., Morham S.G., Zavitz K.H., Wang H.E., Wettstein D.A., Stray K.M., Cote M., Rich R.L., Myszka D.G., and Sundquist W.I. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107 1 (2001) 55-65
34. Gheysen D., Jacobs E., de Foresta F., Thiriart C., Francotte M., Thines D., and De Wilde M. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59 1 (1989) 103-112
35. Goff S.P. "Retroviridae: the retroviruses and their replication.". In: David P.M.H., and Knipes M. (Eds). Fields Virology. fifth ed. II (2007), Lippincott William and Wilkins, Piladelphia, PA, USA II
36. Gorelick R.J., Henderson L.E., Hanser J.P., and Rein A. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc. Natl. Acad. Sci. U. S. A. 85 22 (1988) 8420-8424
37. Gorelick R.J., Nigida Jr. S.M., Bess Jr. J.W., Arthur L.O., Henderson L.E., and Rein A. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J. Virol. 64 7 (1990) 3207-3211
38. Gorelick R.J., Chabot D.J., Rein A., Henderson L.E., and Arthur L.O. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 67 7 (1993) 4027-4036
39. Gorelick R.J., Chabot D.J., Ott D.E., Gagliardi T.D., Rein A., Henderson L.E., and Arthur L.O. Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA. J. Virol. 70 4 (1996) 2593-2597
40. Gorelick R.J., Benveniste R.E., Gagliardi T.D., Wiltrout T.A., Busch L.K., Bosche W.J., Coren L.V., Lifson J.D., Bradley P.J., Henderson L.E., and Arthur L.O. Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo. Virology 253 2 (1999) 259-270
41. Gorelick R.J., Gagliardi T.D., Bosche W.J., Wiltrout T.A., Coren L.V., Chabot D.J., Lifson J.D., Henderson L.E., and Arthur L.O. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences. Virology 256 1 (1999) 92-104
42. Gottlinger H.G., Sodroski J.G., and Haseltine W.A. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U. S. A. 86 15 (1989) 5781-5785
43. Heath M.J., Derebail S.S., Gorelick R.J., and DeStefano J.J. Differing roles of the N- and C-terminal zinc fingers in human immunodeficiency virus nucleocapsid protein-enhanced nucleic acid annealing. J. Biol. Chem. 278 33 (2003) 30755-30763
44. Heidecker G., Lloyd P.A., Soheilian F., Nagashima K., and Derse D. The role of WWP1-Gag interaction and Gag ubiquitination in assembly and release of human T-cell leukemia virus type 1. J. Virol. 81 18 (2007) 9769-9777
45. Hill C.P., Worthylake D., Bancroft D.P., Christensen A.M., and Sundquist W.I. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc. Natl. Acad. Sci. U. S. A. 93 7 (1996) 3099-3104
46. Huang M., Orenstein J.M., Martin M.A., and Freed E.O. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69 11 (1995) 6810-6818
47. Kaye J.F., and Lever A.M. trans-acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1. J. Virol. 70 2 (1996) 880-886
48. Kaye J.F., and Lever A.M. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation. J. Virol. 72 7 (1998) 5877-5885
49. Lapadat-Tapolsky M., Gabus C., Rau M., and Darlix J.L. Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability. J. Mol. Biol. 268 2 (1997) 250-260
50. Lener D., Tanchou V., Roques B.P., Le Grice S.F., and Darlix J.L. Involvement of HIV-I nucleocapsid protein in the recruitment of reverse transcriptase into nucleoprotein complexes formed in vitro. J. Biol. Chem. 273 50 (1998) 33781-33786
51. Levin J.G., Guo J., Rouzina I., and Musier-Forsyth K. Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: critical role in reverse transcription and molecular mechanism. Prog. Nucleic Acid Res. Mol. Biol. 80 (2005) 217-286
52. Lu Y.L., Bennett R.P., Wills J.W., Gorelick R., and Ratner L. A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles. J. Virol. 69 11 (1995) 6873-6879
53. Mammano F., Ohagen A., Hoglund S., and Gottlinger H.G. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J. Virol. 68 8 (1994) 4927-4936
54. Martin-Serrano J., Zang T., and Bieniasz P.D. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7 12 (2001) 1313-1319
55. Martin-Serrano J., Zang T., and Bieniasz P.D. Role of ESCRT-I in retroviral budding. J. Virol. 77 8 (2003) 4794-4804
56. McGrath C.F., Buckman J.S., Gagliardi T.D., Bosche W.J., Coren L.V., and Gorelick R.J. Human cellular nucleic acid-binding protein Zn2+ fingers support replication of human immunodeficiency virus type 1 when they are substituted in the nucleocapsid protein. J. Virol. 77 15 (2003) 8524-8531
57. Meric C., and Spahr P.F. Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging. J. Virol. 60 2 (1986) 450-459
58. Meric C., and Goff S.P. Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein. J. Virol. 63 4 (1989) 1558-1568
59. Meric C., Gouilloud E., and Spahr P.F. Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His boxes. J. Virol. 62 9 (1988) 3328-3333
60. Murakami T., and Freed E.O. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. J. Virol. 74 8 (2000) 3548-3554
61. Muriaux D., Mirro J., Harvin D., and Rein A. RNA is a structural element in retrovirus particles. Proc. Natl. Acad. Sci. U. S. A. 98 9 (2001) 5246-5251
62. Ono A., and Freed E.O. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. J. Virol. 73 5 (1999) 4136-4144
63. Ott D.E., Coren L.V., Chertova E.N., Gagliardi T.D., Nagashima K., Sowder II R.C., Poon D.T., and Gorelick R.J. Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant. J. Virol. 77 10 (2003) 5547-5556
64. Reicin A.S., Paik S., Berkowitz R.D., Luban J., Lowy I., and Goff S.P. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J. Virol. 69 2 (1995) 642-650
65. Rein A., Henderson L.E., and Levin J.G. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends Biochem. Sci. 23 8 (1998) 297-301
66. Rhodes T.D., Nikolaitchik O., Chen J., Powell D., and Hu W.S. Genetic recombination of human immunodeficiency virus type 1 in one round of viral replication: effects of genetic distance, target cells, accessory genes, and lack of high negative interference in crossover events. J. Virol. 79 3 (2005) 1666-1677
67. Rodriguez-Rodriguez L., Tsuchihashi Z., Fuentes G.M., Bambara R.A., and Fay P.J. Influence of human immunodeficiency virus nucleocapsid protein on synthesis and strand transfer by the reverse transcriptase in vitro. J. Biol. Chem. 270 25 (1995) 15005-15011
68. Rong L., Liang C., Hsu M., Guo X., Roques B.P., and Wainberg M.A. HIV-1 nucleocapsid protein and the secondary structure of the binary complex formed between tRNA(Lys.3) and viral RNA template play different roles during initiation of (-) strand DNA reverse transcription. J. Biol. Chem. 276 50 (2001) 47725-47732
69. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
70. Sandefur S., Varthakavi V., and Spearman P. The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag. J. Virol. 72 4 (1998) 2723-2732
71. Sandefur S., Smith R.M., Varthakavi V., and Spearman P. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag). J. Virol. 74 16 (2000) 7238-7249
72. Srinivasakumar N., Hammarskjold M.L., and Rekosh D. Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation. J. Virol. 69 10 (1995) 6106-6114
73. Strack B., Calistri A., Craig S., Popova E., and Gottlinger H.G. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114 6 (2003) 689-699
74. Swanstrom R., and Wills J.W. Synthesis, assembly, and processing of viral proteins. In: Coffin J.M., Hughes S.H., and Varmus H.E. (Eds). Retroviruses (1997), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y 263-334
75. Thomas J.A., Gagliardi T.D., Alvord W.G., Lubomirski M., Bosche W.J., and Gorelick R.J. Human immunodeficiency virus type 1 nucleocapsid zinc-finger mutations cause defects in reverse transcription and integration. Virology 353 1 (2006) 41-51
76. Tsuchihashi Z., and Brown P.O. DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 68 9 (1994) 5863-5870
77. VerPlank L., Bouamr F., LaGrassa T.J., Agresta B., Kikonyogo A., Leis J., and Carter C.A. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc. Natl. Acad. Sci. U. S. A. 98 14 (2001) 7724-7729
78. von Schwedler U.K., Stray K.M., Garrus J.E., and Sundquist W.I. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J. Virol. 77 9 (2003) 5439-5450
79. Wills J.W., and Craven R.C. Form, function, and use of retroviral gag proteins. Aids 5 6 (1991) 639-654
80. Wu L., Martin T.D., Vazeux R., Unutmaz D., and KewalRamani V.N. Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission. J. Virol. 76 12 (2002) 5905-5914
81. Yovandich J.L., Chertova E.N., Kane B.P., Gagliardi T.D., Bess Jr. J.W., Sowder II R.C., Henderson L.E., and Gorelick R.J. Alteration of zinc-binding residues of simian immunodeficiency virus p8(NC) results in subtle differences in gag processing and virion maturation associated with degradative loss of mutant NC. J. Virol. 75 1 (2001) 115-124
82. Yu X.F., Dawson L., Tian C.J., Flexner C., and Dettenhofer M. Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assembly. J. Virol. 72 4 (1998) 3412-3417
83. Zhang Y., and Barklis E. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation. J. Virol. 69 9 (1995) 5716-5722
84. Zhang W.H., Hwang C.K., Hu W.S., Gorelick R.J., and Pathak V.K. Zinc finger domain of murine leukemia virus nucleocapsid protein enhances the rate of viral DNA synthesis in vivo. J. Virol. 76 15 (2002) 7473-7484